Long way to go: Progress of orphan drug accessibility in China from 2017 to 2022

Introduction: Over 400 million patients worldwide suffer from rare diseases. Access to orphan drugs is, therefore, crucial for this population. China has been actively working on improving orphan drug accessibility in the past decades, especially since 2018 when the First National List of Rare Disea...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jia, Yu, Yue, Zhong, Mingkang, Ma, Chunlai, Shao, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031016/
https://www.ncbi.nlm.nih.gov/pubmed/36969835
http://dx.doi.org/10.3389/fphar.2023.1138996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031016/
https://www.ncbi.nlm.nih.gov/pubmed/36969835
http://dx.doi.org/10.3389/fphar.2023.1138996

Ejemplares similares